Achieve Clinical Research, LLC   Report issue

For profit Phase 2 Phase 3
Founded: Vestavia Hills AL United States (1998)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2013
NCT01787188
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

meloxicam (mobic) (1 trial)

Drugs in Phase 2 Trials (1)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Osteoarthritis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2